Discontinuation of questionable therapeutic efficacy drugs during hospitalization
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Poster
- By: GUIU SEGURA, Josep Maria (Hospital Universitari Vall d'Hebron, Barcelona, Spain)
- Co-author(s): Martínez Cutillas, Julio (Hospital Universitari Vall d'Hebron, Barcelona, Spain)
March Pujol, Maria Antonia (Faculty of Pharmacy, University of Barcelona, Barcelona, Spain)
Monterde Junyent, Josep (Hospital Universitari Vall d'Hebron, Barcelona, Spain)
Background and objective: The use of Â questionable therapeutic efficacy (QTE) drugs has been suggested to produce potentially serious interactions in hospitalized patients. Such interactions have both clinical and financial implications. The objective of this study was to assess the acceptance and cost savings deriving from the discontinuation.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.